XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)    
Net loss $ (7,073,062) $ (6,709,524)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 995,192 1,004,633
Non-cash lease expense 135 2,504
Share-based payments for services 396,839 218,386
Equity based compensation 711,381 1,383,909
Common stock contributed to 401(k) plan 57,133 48,907
Loss on patent impairment 9,541 0
(Increase)/decrease in assets:    
Prepaid expenses 79,724 100,546
Supplies used for R&D and manufacturing 193,842 (98,765)
Deposits (4,000) (11,884)
Increase/(decrease) in liabilities:    
Accounts payable 473,514 (765,078)
Accrued expenses (15,291) (8,924)
Due to employees 194,797 148,454
Net cash used in operating activities (4,139,973) (4,887,928)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (32,954) (51,650)
Expenditures for patent costs   (13,211)
Net cash used in investing activities (32,954) (64,861)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock and pre-funded warrants 5,000,300 4,980,000
Payments of stock issuance costs (469,020) (504,913)
Payments on obligations under finance leases (482,411) (426,593)
Net cash provided by financing activities 4,048,869 4,048,494
NET DECREASE IN CASH AND CASH EQUIVALENTS (124,058) (904,295)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 4,738,173 4,145,735
CASH AND CASH EQUIVALENTS, END OF PERIOD 4,614,115 3,241,440
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Finance lease obligation included in accounts payable 1,087 714
Consulting services paid with issuance of common stock 396,087 202,307
Financing costs included in current liabilities 220,220 43,019
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS:    
Cash paid for interest $ 207,735 $ 244,659